COMMUNIQUÉS West-GlobeNewswire

Nexstim Plc: Managers' Transactions
26/04/2019
Company announcement, Helsinki, 26 April 2019 at 4pm (EET) Nexstim Plc: Managers' Transactions Nexstim Plc (NXTMH:HEX, NXTMS:STO) ( "Nexstim" or "Company" ), the targeted neuromodulation company developing and marketing [...]
Chiesi Named Signature Sponsor of the Triangle March for Babies Walk & 5K Run
26/04/2019
The community is invited to walk to support the March of Dimes mission for healthy moms and babies CARY, N.C., April 26, 2019 (GLOBE NEWSWIRE) -- Chiesi is proud to return as the signature sponsor of the 2019 Triangle [...]
Wildflower Featured in CannabisNewsAudio Broadcast Examining Rare Opportunities for Profit in Cannabis Market
26/04/2019
NEW YORK, April 26, 2019 (GLOBE NEWSWIRE) -- via CannabisNewsAudio – Wildflower Brands Inc. (OTCQB:WLDFF) (CSE:SUN) announces the availability of a CannabisNewsAudio Broadcast titled, “The Cannabis Bonanza Has Just [...]
Phoenix Life Announces Annual Financial Report Filings for 2017 and 2018
26/04/2019
DENVER, CO, April 26, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – Phoenix Life Sciences International Limited (OTC: PLSI) (“Phoenix Life”, the “Company”), an international adaptive healthcare solutions company, today [...]
Evolus Receives Positive CHMP Opinion for Nuceiva™ in the European Union
26/04/2019
European Commission Approval Anticipated Within 90 Days NEWPORT BEACH, Calif., April 26, 2019 (GLOBE NEWSWIRE) -- Evolus, Inc. (NASDAQ: EOLS), a performance beauty company with a customer-centric approach focused on [...]
Akari Therapeutics Announces Expanded Ophthalmology Program Based on Positive Emerging Data on LTB4-C5 Dual Action in Surface and Back of the Eye Diseases
26/04/2019
In an experimental back of the eye, autoimmune uveitis (EAU) model to be reported in a poster presentation at ARVO 2019, nomacopan (Coversin) and its long acting variants administered intravitreally, reported: ○ [...]
Oncology Venture Investor Events in Q2 2019 – new event
26/04/2019
Investor news Hørsholm, Denmark and Cambridge, MA, US, April 26th, 2019 – Oncology Venture A/S (“Oncology Venture”) today provided an update regarding when its CEO Peter Buhl Jensen are scheduled to make investor [...]
ReWalk Robotics Regains Compliance with Nasdaq Listing Rules 5550(a) and 5550(b)
26/04/2019
YOKNEAM ILIT, Israel and MARLBOROUGH, Mass., April 26, 2019 (GLOBE NEWSWIRE) -- ReWalk Robotics Ltd. (Nasdaq: RWLK) (“ReWalk” or the “Company”) today announced that it has regained compliance with Nasdaq Listing Rules [...]
Oncology Venture Investor Events in Q2 2019
26/04/2019
Investor news Oncology Venture Investor Events in Q2 2019 Hørsholm, Denmark and Cambridge, MA, US, April 26th, 2019 – Oncology Venture A/S (“Oncology Venture”) today provided an update regarding when its CEO Peter Buhl [...]
Forty Seven Inc. Expands Collaboration with Genentech to Include Third Clinical Trial in Non-Hodgkin’s Lymphoma
26/04/2019
-- Plan to evaluate Forty Seven’s CD47 antibody in combination with Genentech’s CD20 and PD-L1 antibodies with the aim of engaging both T-cell and macrophage components of the immune system against Diffuse Large B-cell [...]
Outlook Therapeutics Announces Addition of Jennifer M. Kissner, Ph.D. as Senior Vice President, Clinical Development
26/04/2019
CRANBURY, N.J., April 26, 2019 (GLOBE NEWSWIRE) -- Outlook Therapeutics, Inc. (NASDAQ: OTLK) (the “Company”), a clinical-stage biopharmaceutical company focused on developing its lead clinical program, ONS-5010, a [...]
Tauriga Sciences Inc. Creates Alternative Version of its Graphic Design for Mint Flavor Tauri-Gum Blister Pack
26/04/2019
New York, NY, April 26, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Tauriga Sciences, Inc. (OTCQB: TAUG ) (“Tauriga” or the “Company”), a revenue generating Company that operates through the development, distribution, [...]
Establishment Labs to Present at UBS Global Healthcare Conference
26/04/2019
NEW YORK, April 26, 2019 (GLOBE NEWSWIRE) -- Establishment Labs Holdings Inc. (NASDAQ: ESTA), a medical technology company focused on women’s health, initially in the breast aesthetics and reconstruction market, today [...]
Mereo Biopharma to Announce Preliminary Results for the Full Year 2018 and Host Conference Call on April 29, 2019
26/04/2019
Mereo BioPharma Group plc ("Mereo" or the "Company" or the "Group") LONDON, April 26, 2019 (GLOBE NEWSWIRE) -- Mereo BioPharma Group plc (AIM: MPH) (NASDAQ: MREO), a clinical stage, UK-based, biopharmaceutical company [...]
Repligen Corporation Announces Agreement to Acquire Process Analytics Innovator C Technologies and Reports Preliminary First Quarter 2019 Financial Results
26/04/2019
Proposed acquisition establishes a key franchise for Repligen in the rapidly growing Process Analytics segment of bioprocessing Adds a market leader in protein concentration measurement with proprietary and [...]
Editorial in Pharmagenomics explains how DRP® can guide the treatment for breast cancer
26/04/2019
Investor News Hørsholm, Denmark and Cambridge, MA, US, April 26, 2019 – Oncology Venture A/S announced today that an editorial published in Pharmagenomics explains how the DRP ® can guide the treatment for breast cancer [...]
CURE Pharmaceutical Named “Innovative Business of the Year” By Oxnard Chamber of Commerce
26/04/2019
OXNARD, Calif., April 26, 2019 (GLOBE NEWSWIRE) -- CURE Pharmaceutical (OTC: CURR) (“CURE”), an innovative drug delivery and development company, has been named 2019’s Innovative Business of the Year by Oxnard Chamber [...]
Inivata publishes positive clinical validation results and real-world utility for its InVisionFirst®-Lung liquid biopsy test
26/04/2019
Inivata publishes positive clinical validation results and real-world utility for its InVisionFirst ® -Lung liquid biopsy test InVisionFirst ® -Lung demonstrated excellent concordance with tissue profiling and detected [...]
miRagen Announces New Clinical Data for Cobomarsen in ATLL Patients at the 19th Annual HTLV Congress in Lima, Peru
26/04/2019
Continued evidence of disease stabilization observed in ATLL patients treated with cobomarsen for up to 16 months Cobomarsen allowed for rapid bone marrow recovery following chemotherapy In most patients, biomarkers [...]

Pages